Defective recombinant adenoviruses with inactivated IVa2 gene
US6200798A · kind A · utility
3Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 1997 |
| Grant date | Mar 13, 2001 |
| Priority date | — |
| Expiry date | Mar 21, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/108
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new viral vectors derived from adenoviruses, their preparation and utilization in gene therapy. It relates particularly to defective recombinant adenoviruses wherein the Iva2 gene at least is inactivated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.